OVID stock forecast
Our latest prediction for Ovid Therapeutics, Inc.'s stock price was made on the Oct. 8, 2019 when the stock price was at 2.44$.
In the short term (2weeks), OVID's stock price should outperform the market by 7.62%. During that period the price should oscillate between -10.75% and +22.54%.
In the medium term (3months), OVID's stock price should outperform the market by 7.07%. During that period the price should oscillate between -23.18% and +51.81%.Get email alerts
Create a solid portfolio with OVID
About Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.73$ per share.
The book value per share is 2.48$
Three months stock forecastOct. 8, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|